JP2007510718A5 - - Google Patents

Download PDF

Info

Publication number
JP2007510718A5
JP2007510718A5 JP2006539449A JP2006539449A JP2007510718A5 JP 2007510718 A5 JP2007510718 A5 JP 2007510718A5 JP 2006539449 A JP2006539449 A JP 2006539449A JP 2006539449 A JP2006539449 A JP 2006539449A JP 2007510718 A5 JP2007510718 A5 JP 2007510718A5
Authority
JP
Japan
Prior art keywords
compound
substituted
nitrogen
cancer
leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006539449A
Other languages
English (en)
Japanese (ja)
Other versions
JP4717003B2 (ja
JP2007510718A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/011638 external-priority patent/WO2005056531A1/en
Publication of JP2007510718A publication Critical patent/JP2007510718A/ja
Publication of JP2007510718A5 publication Critical patent/JP2007510718A5/ja
Application granted granted Critical
Publication of JP4717003B2 publication Critical patent/JP4717003B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006539449A 2003-11-12 2004-04-16 11−o−メチルゲルダナマイシン化合物 Expired - Fee Related JP4717003B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51947903P 2003-11-12 2003-11-12
US60/519,479 2003-11-12
PCT/US2004/011638 WO2005056531A1 (en) 2003-11-12 2004-04-16 11-o-methylgeldanamycin compounds

Publications (3)

Publication Number Publication Date
JP2007510718A JP2007510718A (ja) 2007-04-26
JP2007510718A5 true JP2007510718A5 (https=) 2007-06-14
JP4717003B2 JP4717003B2 (ja) 2011-07-06

Family

ID=34676572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006539449A Expired - Fee Related JP4717003B2 (ja) 2003-11-12 2004-04-16 11−o−メチルゲルダナマイシン化合物

Country Status (5)

Country Link
US (1) US6870049B1 (https=)
EP (1) EP1682514A4 (https=)
JP (1) JP4717003B2 (https=)
CA (1) CA2545457A1 (https=)
WO (1) WO2005056531A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259156B2 (en) 2004-05-20 2007-08-21 Kosan Biosciences Incorporated Geldanamycin compounds and method of use
WO2007059116A2 (en) * 2005-11-14 2007-05-24 Abraxis Bioscience, Inc. Geldanamycin derivatives and pharmaceutical compositions thereof
US20070207992A1 (en) * 2006-02-21 2007-09-06 Board Of Trustees Of Michigan State University Geldanamycin derivatives and method of use thereof
DE102006044472A1 (de) * 2006-09-21 2008-04-03 Discovery Partner International Gmbh Geldanamycin-Derivate
US8466140B2 (en) * 2007-09-10 2013-06-18 University Of Massachusetts Mitochondria-targeted anti-tumor agents

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987035A (en) 1974-04-05 1976-10-19 University Of Illinois Foundation Biologically active compounds
US4261989A (en) 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
JPS5874651A (ja) 1981-09-17 1983-05-06 Takeda Chem Ind Ltd マクベシン誘導体およびその製造法
US4421687A (en) 1981-09-26 1983-12-20 Takeda Chemical Industries, Limited Macbecin derivatives
JPS59102398A (ja) 1982-12-03 1984-06-13 Takeda Chem Ind Ltd 新規抗生物質およびその製造法
JPS63218620A (ja) 1987-03-09 1988-09-12 Kyowa Hakko Kogyo Co Ltd 癌化細胞の正常化剤
JPH0446120A (ja) 1990-06-11 1992-02-17 Kyowa Hakko Kogyo Co Ltd 血管新生抑制剤
FI943207A0 (fi) 1992-01-06 1994-07-05 Pfizer 4,5-dihydrogeldanamysiinin ja sen hydrokinonin valmistusmenetelmä ja käyttö
AU5360694A (en) 1992-10-14 1994-05-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies
US5387584A (en) 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
CA2166320A1 (en) 1993-06-29 1995-01-12 Randall James Gallaschun Ansamycin derivatives as antioncogene and anticancer agents
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US5662883A (en) 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5534270A (en) 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
EP0828418A4 (en) 1995-05-02 2000-03-29 Univ California INDUCTION OF THERMOTOLERANCE WITH BENZOCHINOIDS ANSAMYCINES
WO2000003737A2 (en) 1998-07-17 2000-01-27 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Water-soluble drugs and methods for their production
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
AU2002217866A1 (en) * 2000-11-06 2002-05-15 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Geldanamycin derivatives useful for the treatment of cancer
EP1373215B1 (en) * 2001-03-30 2006-07-26 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Geldanamycin derivatives useful for treating cancer
WO2003013430A2 (en) 2001-08-06 2003-02-20 Kosan Biosciences, Inc. Benzoquinone ansamycins
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1472230B1 (en) 2002-02-08 2009-06-17 Conforma Therapeutic Corporation Ansamycins having improved pharmacological and biological properties
BRPI0408891A (pt) * 2003-03-28 2006-04-11 Kosan Biosciences Inc dispositivos, métodos, e composições para prevenir restenose

Similar Documents

Publication Publication Date Title
JP2010504346A5 (https=)
JP2006505543A5 (https=)
JP2010531304A5 (https=)
KR101982951B1 (ko) 신규한 유형의 시티딘 유도체 및 그의 용도
JP2011509949A5 (https=)
JP2008510770A5 (https=)
RU2005128190A (ru) Ингибиторы фактора подавления миграции макрофагов (фпм) и способы их идентификации
JP2004506606A (ja) 抗ウイルスピリミジンヌクレオシド類
JP2014500870A5 (https=)
JP2009504764A5 (https=)
CA2605738A1 (en) Novel azaheterocyclic compounds as kinase inhibitors
JP2005533835A5 (https=)
JP2011509309A5 (https=)
JP2018524403A5 (https=)
JP2008511601A5 (https=)
RU2020102453A (ru) Фармацевтические композиции
JP6165744B2 (ja) Rasアンタゴニストによる悪性および非悪性疾患の治療
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2006501201A5 (https=)
JP2002527414A5 (https=)
JP2009539943A5 (https=)
JP2019519593A5 (https=)
CA2589850A1 (en) Amide prodrug of gemcitabine, compositions and use thereof
JP2007502832A5 (https=)
JP2008545718A5 (https=)